早期脑电图高兴奋性与新诊断IDH野生型胶质瘤生存期缩短相关
本研究为回顾性观察性队列研究,纳入新诊断IDH野生型弥漫性胶质瘤成人患者,在放化疗前且初次切除术后1个月内进行连续脑电图监测。脑电图高兴奋性定义为存在侧化周期性放电和/或脑电发作。结果显示,围手术期脑电图高兴奋性与总生存期缩短相关(中位12.5个月 vs 19.9个月,p=0.043)。
要点
- 围手术期连续脑电图高兴奋性与IDH野生型胶质瘤总生存期缩短相关。
- 高兴奋性组中位总生存期12.5个月,无高兴奋性组为19.9个月(p=0.043)。
- 高兴奋性与无高兴奋性患者基线抗癫痫药物暴露率及长期癫痫控制所需药物数量无差异。
核心结论
- 研究结果表明,放化疗开始前脑电图高兴奋性作为胶质瘤侵袭性的临床生物标志物具有潜在预后价值。
研究设计与样本
- 回顾性观察性队列研究,纳入新诊断弥漫性胶质瘤、无IDH1/2突变、在放化疗前且初次切除术后1个月内接受连续脑电图监测的成人患者。
- 共424例患者未接受连续脑电图,32例接受连续脑电图,其中17例(53%)可见侧化周期性放电和/或脑电发作。
主要发现
- 多因素分析显示,围手术期脑电图高兴奋性与总生存期缩短相关(中位12.5 [95% CI 6.2-25.6]个月 vs 中位19.9 [95% CI 8.9-53.5]个月,p=0.043)。
- 与未接受连续脑电图的患者相比,高兴奋性患者总生存期缩短(p<0.0001),而无高兴奋性患者总生存期相似(p=0.193)。
- 高兴奋性与无高兴奋性患者基线抗癫痫药物暴露率相似,长期随访中癫痫控制所需药物数量无差异。
关键数值与推荐
- 脑电图高兴奋性定义为存在侧化周期性放电和/或脑电发作。
- 主要结局总生存期采用Kaplan-Meier法估计,组间比较采用多因素Cox比例风险模型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The relationship between peritumoral neuronal activity, early onset clinical seizures, and glioma survival outcomes remains poorly understood. Hyperexcitability on continuous EEG in the peri-operative period was studied as a prognostic biomarker in patients with newly diagnosed IDH-wildtype diffuse glioma. METHODS: A retrospective observational cohort study was performed including adults with newly diagnosed diffuse glioma, absence of IDH1/2 mutations, and continuous EEG monitoring prior to chemoradiation and within 1 month of initial resection. EEG hyperexcitability was defined by the presence of lateralized periodic discharges and/or electrographic seizures. The primary outcome of overall survival was estimated using the Kaplan-Meier method and compared between groups using multivariate Cox proportional hazards model. RESULTS: There were 424 patients without continuous EEG and 32 with continuous EEG, of whom lateralized periodic discharges and/or electrographic seizures were seen in 17 (53%). Peri-operative EEG hyperexcitability was associated with decreased overall survival in multivariate analysis (median 12.5 [95% CI 6.2-25.6] months with hyperexcitability versus median 19.9 [95% CI 8.9-53.5] months without hyperexcitability, p = 0.043). Compared to patients without continuous EEG, overall survival was decreased in patients with hyperexcitability (p < 0.0001) and similar in patients without hyperexcitability (p = 0.193). Patients with and without hyperexcitability had similar rates of exposure to anti-seizure medication at baseline, and in long-term follow-up had no difference in number of medications required for seizure control. CONCLUSIONS: These findings indicate the potential prognostic value of a clinical EEG biomarker of glioma aggressiveness prior to the initiation of chemoradiation.
引用
- Tobochnik S, Lapinskas E, Vogelzang J, et al. Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma. J Neurooncol. 2022. PMID: 35715666. doi:10.1007/s11060-022-04059-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。